{
    "startDate": "2020-01-01",
    "endDate": "2020-03-31",
    "year": "2020",
    "quarter": "Q1",
    "symbol": "TROV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 9277025
            },
            {
                "label": "Accounts receivable and unbilled receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 106432
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 899451
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 10282908
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 758503
            },
            {
                "label": "Decrease in operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 617622
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 156370
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 11815403
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 598985
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 3411723
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 870592
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4881300
            },
            {
                "label": "Derivative financial instruments\u2014warrants",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2020
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 649621
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 139044
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 5671985
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value, 20,000,000 shares authorized; 277,100 designated as Series A Convertible Preferred Stock; 60,600 shares outstanding at March 31, 2020 and December 31, 2019 with liquidation preference of $606,000 at March 31, 2020 and December 31, 2019; 200,000 designated as Series C Convertible Preferred Stock; 0 shares outstanding at March 31, 2020 and December 31, 2019",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 60
            },
            {
                "label": "Common stock, $0.0001 par value, 150,000,000 shares authorized; 11,010,587 and 8,593,633 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 8554
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 219805965
            },
            {
                "label": "Service receivables",
                "concept": "trov:Servicereceivable",
                "unit": "usd",
                "value": 678656
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -212992505
            },
            {
                "label": "Stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 6143418
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 11815403
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -4088562
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 119320
            },
            {
                "label": "Authorized shares under the plan (in shares)",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 177309
            },
            {
                "label": "Gain (loss) from change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": 2107
            },
            {
                "label": "Release of clinical trial funding commitment",
                "concept": "trov:Releaseofclinicaltrialfundingcommitmentforservicesreceived",
                "unit": "usd",
                "value": 293017
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -1206
            },
            {
                "label": "Accounts receivable and unbilled receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -97048
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": -55506
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": -79796
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 88283
            },
            {
                "label": "Operating lease liabilities",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -206129
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 10676
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -3374637
            },
            {
                "label": "Capital expenditures",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sales of common stock and warrants",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 1000001
            },
            {
                "label": "Costs related to the clinical trial funding commitment",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 1456369
            },
            {
                "label": "Financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 2456370
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -918267
            },
            {
                "label": "Cash paid for taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 800
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "trov:PreferredStockDividendAccrued",
                "unit": "usd",
                "value": 6060
            },
            {
                "label": "Deemed dividend recognized for beneficial conversion features of Convertible Preferred Stock issuance",
                "concept": "trov:DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, preferred stock and warrants issued in connection with clinical trial funding commitment",
                "concept": "trov:Commonstockpreferredstockandwarrantsissuedinconnectionwithclinicaltrialfundingcommitment",
                "unit": "usd",
                "value": 0
            }
        ],
        "ic": [
            {
                "label": "Royalties",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 67704
            },
            {
                "label": "Revenues [Abstract]",
                "concept": "Revenues",
                "unit": "usd",
                "value": 67704
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2705691
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1486019
            },
            {
                "label": "Costs and expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 4191710
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -4124006
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 35823
            },
            {
                "label": "Gain (loss) from change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": 2107
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -2486
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -4088562
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "PreferredStockDividendsIncomeStatementImpact",
                "unit": "usd",
                "value": 6060
            },
            {
                "label": "Deemed dividend recognized for beneficial conversion features of Convertible Preferred Stock issuance",
                "concept": "trov:DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net loss attributable to common stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -4094622
            },
            {
                "label": "Net loss per common share - basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.41
            },
            {
                "label": "Weighted-average shares outstanding - basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 9910306
            }
        ]
    }
}